BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10704057)

  • 1. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
    El-Shazly A; Ishikawa T
    Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis.
    El-Shazly A; Yamaguchi N; Masuyama K; Suda T; Ishikawa T
    Biochem Biophys Res Commun; 1999 Oct; 264(1):163-70. PubMed ID: 10527858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
    El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
    J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
    El-Shazly A; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():10-3. PubMed ID: 9758889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eotaxin potentiates antigen-dependent basophil IL-4 production.
    Devouassoux G; Metcalfe DD; Prussin C
    J Immunol; 1999 Sep; 163(5):2877-82. PubMed ID: 10453034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S; Proost P; Schols D; De Clercq E; Opdenakker G; Lenaerts JP; Detheux M; Parmentier M; De Meester I; Scharpé S; Van Damme J
    J Immunol; 1999 Apr; 162(8):4903-9. PubMed ID: 10202035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system.
    Ferland C; Guilbert M; Davoine F; Flamand N; Chakir J; Laviolette M
    J Leukoc Biol; 2001 May; 69(5):772-8. PubMed ID: 11358986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines induce eosinophil degranulation through CCR-3.
    Fujisawa T; Kato Y; Nagase H; Atsuta J; Terada A; Iguchi K; Kamiya H; Morita Y; Kitaura M; Kawasaki H; Yoshie O; Hirai K
    J Allergy Clin Immunol; 2000 Sep; 106(3):507-13. PubMed ID: 10984371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
    Powell WS; Ahmed S; Gravel S; Rokach J
    J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of eotaxin on the surface adhesion molecules of endothelial cells and on eosinophil adhesion to microvascular endothelial cells.
    Hohki G; Terada N; Hamano N; Kitaura M; Nakajima T; Yoshie O; Ikeda T; Kimura S; Konno A
    Biochem Biophys Res Commun; 1997 Dec; 241(1):136-41. PubMed ID: 9405247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eotaxin is a potent chemotaxin for human basophils.
    Yamada H; Hirai K; Miyamasu M; Iikura M; Misaki Y; Shoji S; Takaishi T; Kasahara T; Morita Y; Ito K
    Biochem Biophys Res Commun; 1997 Feb; 231(2):365-8. PubMed ID: 9070280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
    Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
    J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.
    Kitaura M; Nakajima T; Imai T; Harada S; Combadiere C; Tiffany HL; Murphy PM; Yoshie O
    J Biol Chem; 1996 Mar; 271(13):7725-30. PubMed ID: 8631813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase, and PI 3-kinase.
    Badewa AP; Heiman AS
    Immunopharmacol Immunotoxicol; 2003 May; 25(2):145-57. PubMed ID: 12784909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.